CONSYNANCE THERAPEUTICS Trademark

Trademark Overview

On Tuesday, September 8, 2015, a trademark application was filed for CONSYNANCE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CONSYNANCE THERAPEUTICS trademark a serial number of 86749993. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, October 20, 2022. This trademark is owned by ConSynance Therapeutics, Inc.. The CONSYNANCE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
consynance therapeutics

General Information

Serial Number86749993
Word MarkCONSYNANCE THERAPEUTICS
Filing DateTuesday, September 8, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, October 20, 2022
Registration Number5048078
Registration DateTuesday, September 27, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2016

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 11, 2015
Primary Code042
First Use Anywhere DateThursday, July 30, 2015
First Use In Commerce DateThursday, July 30, 2015

Trademark Owner History

Party NameConSynance Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSchnectady, NY 12303
Party NameConSynance Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSchnectady, NY 12303
Party NameConSynance Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSchnectady, NY 12303

Trademark Events

Event DateEvent Description
Saturday, December 19, 2015ASSIGNED TO EXAMINER
Saturday, December 19, 2015NON-FINAL ACTION WRITTEN
Friday, September 11, 2015NEW APPLICATION ENTERED
Friday, September 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 19, 2015NON-FINAL ACTION E-MAILED
Saturday, December 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 22, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 23, 2016ASSIGNED TO LIE
Tuesday, May 31, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 31, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 1, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 6, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 12, 2016PUBLISHED FOR OPPOSITION
Tuesday, July 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2016REGISTERED-PRINCIPAL REGISTER
Monday, September 27, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, October 20, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 17, 2017TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, June 30, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 31, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 31, 2017REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Wednesday, April 20, 2022TEAS SECTION 8 & 15 RECEIVED
Saturday, September 27, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, October 20, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, October 20, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

therapeutics consynance development research pharmaceutical